| Date | Name | Shares | Transaction | Value |
|
Jan 8, 2026
| Omar Marwan Asali CEO & Executive Chairman; Director |
2,683,641
| Payment of exercise price or tax liability by delivering/withholding secs incident to the receipt/exercise/vesting pursuant to Rule 16b-3 Non-derivative transaction at $5.53 per share |
14,840,534.73
|
|
Jan 8, 2026
| William E. Drew Chief Financial Officer & EVP |
526,571
| Payment of exercise price or tax liability by delivering/withholding secs incident to the receipt/exercise/vesting pursuant to Rule 16b-3 Non-derivative transaction at $5.53 per share |
2,911,937.63
|
|
Jan 8, 2026
| Michael A. Jones Director |
268,554
| Grant, award or other acq pursuant to Rule 16b-3(d) Non-derivative transaction at $5.53 per share |
1,485,103.62
|
|
Jan 8, 2026
| Alicia M. Tranen Director |
298,062
| Grant, award or other acq pursuant to Rule 16b-3(d) Non-derivative transaction at $5.53 per share |
1,648,282.86
|
|
Jan 8, 2026
| Salil Seshadri Director |
551,178
| Grant, award or other acq pursuant to Rule 16b-3(d) Non-derivative transaction at $5.53 per share |
3,048,014.34
|
|
Jan 8, 2026
| Michael S. Gliedman Director |
144,263
| Payment of exercise price or tax liability by delivering/withholding secs incident to the receipt/exercise/vesting pursuant to Rule 16b-3 Non-derivative transaction at $5.53 per share |
797,774.39
|
|
Mar 21, 2025
| Omar Marwan Asali CEO & Executive Chairman; Director |
2,730,193
| Payment of exercise price or tax liability by delivering/withholding secs incident to the receipt/exercise/vesting pursuant to Rule 16b-3 Non-derivative transaction at $6.02 per share |
16,435,761.86
|
|
Mar 21, 2025
| William E. Drew Chief Financial Officer & EVP |
541,394
| Payment of exercise price or tax liability by delivering/withholding secs incident to the receipt/exercise/vesting pursuant to Rule 16b-3 Non-derivative transaction at $6.02 per share |
3,259,191.88
|
|
Mar 21, 2025
| Eric Laurensse Managing Director, Europe |
211,834
| Grant, award or other acq pursuant to Rule 16b-3(d) |
0.00
|
|
Mar 21, 2025
| Eric Laurensse Managing Director, Europe |
206,049
| Payment of exercise price or tax liability by delivering/withholding secs incident to the receipt/exercise/vesting pursuant to Rule 16b-3 Non-derivative transaction at $6.02 per share |
1,240,414.98
|
|
Mar 21, 2025
| Mark Allan Siebert MD, North America |
111,904
| Grant, award or other acq pursuant to Rule 16b-3(d) |
0.00
|
|
Mar 21, 2025
| Mark Allan Siebert MD, North America |
109,532
| Payment of exercise price or tax liability by delivering/withholding secs incident to the receipt/exercise/vesting pursuant to Rule 16b-3 Non-derivative transaction at $6.02 per share |
659,382.64
|
|
Mar 21, 2025
| Michael S. Gliedman Director |
152,550
| Payment of exercise price or tax liability by delivering/withholding secs incident to the receipt/exercise/vesting pursuant to Rule 16b-3 Non-derivative transaction at $6.02 per share |
918,351.00
|
|
Mar 21, 2025
| Antonio Grassotti Managing Director, APAC |
188,856
| Grant, award or other acq pursuant to Rule 16b-3(d) |
0.00
|